196-210 of 931
Comparing Photodynamic Therapy Approaches in Basal Cell Carcinoma
AudioAbstractsComparing Photodynamic Therapy Approaches in Basal Cell Carcinoma
Ryan Quigley
Closing Gaps in CRC Screening: Patient-Centered Strategies
On the Frontlines of Colorectal CancerClosing Gaps in CRC Screening: Patient-Centered Strategies
Peter Buch, MD, FACG, AGAF, FACP
Concurrent Atezolizumab Fails to Improve Survival in Limited-Stage SCLC
Project Oncology®Concurrent Atezolizumab Fails to Improve Survival in Limited-Stage SCLC
ESTI Refines Pulmonary Nodule Management in Lung Cancer Screening
Project Oncology®ESTI Refines Pulmonary Nodule Management in Lung Cancer Screening
Are E-Cigarettes Safer? A Closer Look at Lung Cancer Risk
AudioAbstractsAre E-Cigarettes Safer? A Closer Look at Lung Cancer Risk
Ryan Quigley
Updates in AML Care: Evolving ASH Guidelines for Older Adults
On the Frontlines of AML/ALLUpdates in AML Care: Evolving ASH Guidelines for Older Adults
Shelina Ramnarine, PhD
Mikkael A. Sekeres, MD, MS
- advertisement
Venetoclax and Palbociclib in AML: Exploring New Findings
On the Frontlines of AML/ALLVenetoclax and Palbociclib in AML: Exploring New Findings
Ryan Quigley
Jeffrey Tyner, PhD
Melissa Stewart, PhD
Advancing Relapse Prediction in Pediatric AML Through Genomic MRD
On the Frontlines of AML/ALLAdvancing Relapse Prediction in Pediatric AML Through Genomic MRD
Ryan Quigley
Amanda Winters, MD, PhD
Understanding the Growing Burden of Early-Onset CRC
On the Frontlines of Colorectal CancerUnderstanding the Growing Burden of Early-Onset CRC
Ryan Quigley
Christopher Cann, MD
Decoding Co-Mutations in HR+, HER2- Metastatic Breast Cancer
On the Frontlines of Metastatic Breast CancerDecoding Co-Mutations in HR+, HER2- Metastatic Breast Cancer
Abirami Sivapiragasam
Neighborhood Archetypes and Patient Outcomes in Pediatric ALL and AML
On the Frontlines of AML/ALLNeighborhood Archetypes and Patient Outcomes in Pediatric ALL and AML
Charles Turck, PharmD, BCPS, BCCCP
Lena Winestone, MD, MSHP
Improving BCC Screening in Childhood Cancer Survivors Through Risk Modeling
AudioAbstractsImproving BCC Screening in Childhood Cancer Survivors Through Risk Modeling
Ryan Quigley
- advertisement
Cosibelimab Delivers Durable Responses in Advanced CSCC
Project Oncology®Cosibelimab Delivers Durable Responses in Advanced CSCC
Neoadjuvant Nivolumab With or Without Ipilimumab in Resectable CSCC
Project Oncology®Neoadjuvant Nivolumab With or Without Ipilimumab in Resectable CSCC
Jobelle Baldonado, MD